News | July 01, 2022
Akebia Therapeutics regaining rights to Vadadustat in the US, Europe and China
Companies finalize termination with an agreed-upon settlement fee of $55M to be paid to Akebia
Companies finalize termination with an agreed-upon settlement fee of $55M to be paid to Akebia
The total covered market size of four brands – Z&D, Pediclory, Pecef & Ezinapi combined is Rs 1800 crores
NADMED technology is based on proprietary extraction and the individual measurement of NAD metabolites
The settlement and dismissal resolves all claims between the parties
Safety in these pediatric populations was consistent with the known safety profile across approved adult and pediatric indications1,2
Medidata Detect and Rave CTMS Have Improved Study Execution Through Role-Based Monitoring Workflows and Clinical Data Visualization for Hundreds of Customers Across More Than 9,000 Studies
73% have cited fears like losing eyesight, painful procedure or long recovery period when it comes to cataract surgeries
Aurobindo Pharma Foundation endeavours to make a positive contribution to the underprivileged ommunities by supporting a wide range of socio-economic, educational, and health initiatives.
The FDA informed Astellas that it did not have sufficient information to assess the risks to subjects
Dr. Reddy's acquired the Eton portfolio for an upfront payment of approximately $5 million in cash, plus contingent payments of up to $45 million.
Subscribe To Our Newsletter & Stay Updated
